ZEB1 transcription factor induces tumor cell PD-L1 expression in melanoma
Abstract Tumor cells can evade antitumor immune response by expressing the PD-L1 ligand, leading to the inhibition of PD-1-expressing T lymphocytes. The mechanisms that regulate PD-L1 expression in cancer cells are imperfectly characterized. The transcription factor ZEB1, a major regulator of phenot...
Saved in:
| Main Authors: | Chloé Wirbel, Simon Durand, Félix Boivin, Maud Plaschka, Valentin Benboubker, Maxime Grimont, Laetitia Barbollat-Boutrand, Garance Tondeur, Brigitte Balme, Olivier Harou, Anaïs Eberhardt, Stéphane Dalle, Jonathan Lopez, Julie Caramel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-03-01
|
| Series: | Cancer Immunology, Immunotherapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s00262-025-03978-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ZEB1 stratifies the response to Sorafenib and Mdivi-1 combination therapy in hepatocellular carcinoma
by: H. Freudenstein, et al.
Published: (2025-08-01) -
MAZ-mediated N6-methyladenosine modification of ZEB1 promotes hepatocellular carcinoma progression by regulating METTL3
by: Di Li, et al.
Published: (2025-03-01) -
ZEB1 transcription factor promotes immune escape in melanoma
by: Christophe Caux, et al.
Published: (2022-03-01) -
ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors
by: Geoffrey Richard, et al.
Published: (2016-09-01) -
Customized Hydrogel System for the Spatiotemporal Sequential Treatment of Periodontitis Propelled by ZEB1
by: Jiafei Chen, et al.
Published: (2025-07-01)